Records 1 - 18
| Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer.
Thorax 2021 Apr .
Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno
| Severe toxicity in adult patients with lung cancer under treatment with pemetrexed: a prospective cohort study.
Journal of chemotherapy (Florence, Italy) 2019 Feb 1-10.
Vázquez Carolina, Orlova María, Verzura María Alicia, Minatta José Nicolás, Scibona Paula, Jáuregui Esteban Gabriel, Díaz de Arce Heidy, Pallotta María Guadalupe, Belloso Waldo Horac
| Folate/homocysteine metabolism and lung cancer risk among smokers.
PloS one 2019 14 (4): e0214462.
Stanislawska-Sachadyn Anna, Borzyszkowska Joanna, Krzeminski Michal, Janowicz Alicja, Dziadziuszko Rafal, Jassem Jacek, Rzyman Witold, Limon Janu
| Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population.
Current problems in cancer 2018 Jul .
Feng Wei, Guo Xianling, Huang Haidong, Xu Chang, Li Yutao, Guo Shicheng, Zhao Zhenghong, Li Qiang, Lu Daru, Jin Li, Wang Jiucun, Jiang Gengxi, Wu Junj
| Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Cancer chemotherapy and pharmacology 2016 Mar 77 (3): 583-93.
Zhang Quan, Sun Tianyu, Kang Poming, Qian Kai, Deng Bo, Zhou Jinghai, Wang Ruwen, Jiang Bin, Li Kun, Liu Fang, Wu Shiyang, Tan Quny
| Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC.
The Journal of international medical research 2016 Feb 44 (1): 89-98.
Zhou Hongxuan, Dai Yun, Zhu Liqun, Wang Chun, Fei Xiaodong, Pan Qin, Chen Juxiang, Shi Xianqing, Yang Yanfeng, Tao Xiaoxing, Shi Pinghu
| Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Apr .
Dong Honglin, Bao Dengke, Guo Xu, Hu Jie, Li Xiaofei, Wan Shaogui, Xing Jinlia
| Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
Journal of cancer research and clinical oncology 2014 Dec 140 (12): 2097-105.
Deng Li-Li, Deng Hong-Bin, Lu Chang-Lian, Guo Yang, Wang Di, Yan Chun-Hua, Lv Xing, Shao Yu-X
| Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.
Cancer chemotherapy and pharmacology 2014 Dec 74 (6): 1149-57.
Kanazawa Kenya, Yokouchi Hiroshi, Wang Xintao, Ishida Takashi, Fujita Yuka, Fujiuchi Satoru, Harada Toshiyuki, Harada Masao, Takamura Kei, Oizumi Satoshi, Kinoshita Ichiro, Katsuura Yutaka, Honjo Osamu, Kojima Tetsuya, Dosaka-Akita Hirotoshi, Isobe Hiroshi, Munakata Mitsuru, Nishimura Masaharu,
| MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2014 Sep 85 (3): 442-8.
Xu Jiali, Tian Shengwang, Yin Zhiqiang, Wu Shuangshuang, Liu Lingxiang, Qian Yingying, Pei Dong, Gao Wen, Xu Jing, Yin Yongmei, Liu Ping, Shu Yongqi
| Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
Molecular biology reports 2014 May 41 (5): 3349-57.
Lima Aurea, Seabra Vítor, Martins Sandra, Coelho Ana, Araújo António, Medeiros R
| Thymidylate synthase gene copy number as a predictive marker for response to pemetrexed treatment of lung adenocarcinoma.
Anticancer research 2013 May 33 (5): 1935-40.
Kasai Daishi, Ozasa Hiroaki, Oguri Tetsuya, Miyazaki Mikinori, Uemura Takehiro, Takakuwa Osamu, Kunii Eiji, Ohkubo Hirotsugu, Maeno Ken, Niimi Ak
| Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer.
PloS one 2013 8 (1): 1.
Swartz MD, Peterson CB, Lupo PJ, Wu X, Forman MR, Spitz MR, Hernandez LM, Vannucci M, Shete S
| Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer.
Oncology letters 2012 Feb 3 (2): 415-420.
Lu Hong-Yang, Su Dan, Pan Xiao-Dan, Jiang Hong, Ma Sheng-L
| Influence of polymorphisms in MTHFR 677 C?T, TYMS 3R?2R and MTR 2756 A?G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Pharmacogenomics 2011 Jun 12 (6): 797-808.
Cui Lian-Hua, Yu Zhuang, Zhang Ting-Ting, Shin Min-Ho, Kim Hee-Nam, Choi Jin-
| Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population.
Lung cancer (Amsterdam, Netherlands) 2008 Jul 61 (1): 21-9.
Liu Hongliang, Jin Guangfu, Wang Haifeng, Wu Wenting, Liu Yanhong, Qian Ji, Fan Weiwei, Ma Hongxia, Miao Ruifen, Hu Zhibin, Sun Weiwei, Wang Yi, Jin Li, Wei Qingyi, Shen Hongbing, Huang Wei, Lu Da
| Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.
Carcinogenesis 2005 Mar 26 (3): 649-56.
Shi Qiuling, Zhang Zhengdong, Neumann Ana S, Li Guojun, Spitz Margaret R, Wei Qing
| The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 19 (4): 1024-8.
Cavic Milena, Krivokuca Ana, Spasic Jelena, Brotto Ksenija, Malisic Emina, Radosavljevic Davorin, Radulovic Sinisa, Jankovic Radmi